Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Chromosome 9q and 16q loss identified by genome-wide pooled-analysis are associated with tumor aggressiveness in patients with classic medulloblastoma.

Coco S, Valdora F, Bonassi S, Scaruffi P, Stigliani S, Oberthuer A, Berthold F, Andolfo I, Servidei T, Riccardi R, Basso E, Iolascon A, Tonini GP.

OMICS. 2011 May;15(5):273-80. doi: 10.1089/omi.2010.0103. Epub 2011 Feb 24.

PMID:
21348762
2.

[Detection of chromosomal DNA imbalance in medulloblastoma by comparative genomic hybridization].

Sun YJ, Yu SZ, Sun CY, Wang Q, Jin SM, Wu WX, An TL.

Zhonghua Bing Li Xue Za Zhi. 2010 Sep;39(9):606-10. Chinese.

PMID:
21092588
3.

[Genome-wide genetic study of medulloblastoma using allelotype analysis].

Yin XL, Pang CS, Ng HK.

Zhonghua Bing Li Xue Za Zhi. 2004 Oct;33(5):413-5. Chinese.

PMID:
15498208
4.

Genome wide copy number abnormalities in pediatric medulloblastomas as assessed by array comparative genome hybridization.

Lo KC, Rossi MR, Eberhart CG, Cowell JK.

Brain Pathol. 2007 Jul;17(3):282-96. Epub 2007 Apr 23.

PMID:
17465989
5.

Isochromosome 17q is a negative prognostic factor in poor-risk childhood medulloblastoma patients.

Pan E, Pellarin M, Holmes E, Smirnov I, Misra A, Eberhart CG, Burger PC, Biegel JA, Feuerstein BG.

Clin Cancer Res. 2005 Jul 1;11(13):4733-40.

6.

Chromosome 17 alterations identify good-risk and poor-risk tumors independently of clinical factors in medulloblastoma.

McCabe MG, Bäcklund LM, Leong HS, Ichimura K, Collins VP.

Neuro Oncol. 2011 Apr;13(4):376-83. doi: 10.1093/neuonc/noq192. Epub 2011 Feb 2.

7.

Biological and clinical heterogeneity of MYCN-amplified medulloblastoma.

Korshunov A, Remke M, Kool M, Hielscher T, Northcott PA, Williamson D, Pfaff E, Witt H, Jones DT, Ryzhova M, Cho YJ, Wittmann A, Benner A, Weiss WA, von Deimling A, Scheurlen W, Kulozik AE, Clifford SC, Peter Collins V, Westermann F, Taylor MD, Lichter P, Pfister SM.

Acta Neuropathol. 2012 Apr;123(4):515-27. doi: 10.1007/s00401-011-0918-8. Epub 2011 Dec 9.

PMID:
22160402
8.

Array CGH analysis of pediatric medulloblastomas.

Rossi MR, Conroy J, McQuaid D, Nowak NJ, Rutka JT, Cowell JK.

Genes Chromosomes Cancer. 2006 Mar;45(3):290-303.

PMID:
16320246
9.

Correlation of loss of heterozygosity at chromosome 9q with histological subtype in medulloblastomas.

Schofield D, West DC, Anthony DC, Marshal R, Sklar J.

Am J Pathol. 1995 Feb;146(2):472-80.

10.

Adult and pediatric medulloblastomas are genetically distinct and require different algorithms for molecular risk stratification.

Korshunov A, Remke M, Werft W, Benner A, Ryzhova M, Witt H, Sturm D, Wittmann A, Schöttler A, Felsberg J, Reifenberger G, Rutkowski S, Scheurlen W, Kulozik AE, von Deimling A, Lichter P, Pfister SM.

J Clin Oncol. 2010 Jun 20;28(18):3054-60. doi: 10.1200/JCO.2009.25.7121. Epub 2010 May 17.

PMID:
20479417
11.

Genetic alterations in childhood medulloblastoma analyzed by comparative genomic hybridization.

Michiels EM, Weiss MM, Hoovers JM, Baak JP, Voûte PA, Baas F, Hermsen MA.

J Pediatr Hematol Oncol. 2002 Mar-Apr;24(3):205-10.

PMID:
11990307
12.
13.

Prognostic significance of chromosome 17p deletions in childhood primitive neuroectodermal tumors (medulloblastomas) of the central nervous system.

Biegel JA, Janss AJ, Raffel C, Sutton L, Rorke LB, Harper JM, Phillips PC.

Clin Cancer Res. 1997 Mar;3(3):473-8.

14.

Identification of a novel homozygous deletion region at 6q23.1 in medulloblastomas using high-resolution array comparative genomic hybridization analysis.

Hui AB, Takano H, Lo KW, Kuo WL, Lam CN, Tong CY, Chang Q, Gray JW, Ng HK.

Clin Cancer Res. 2005 Jul 1;11(13):4707-16.

15.

Microsatellite analysis of loss of heterozygosity on chromosomes 9q, 11p and 17p in medulloblastomas.

Albrecht S, von Deimling A, Pietsch T, Giangaspero F, Brandner S, Kleihues P, Wiestler OD.

Neuropathol Appl Neurobiol. 1994 Feb;20(1):74-81.

PMID:
8208343
16.

Extensive genomic abnormalities in childhood medulloblastoma by comparative genomic hybridization.

Reardon DA, Michalkiewicz E, Boyett JM, Sublett JE, Entrekin RE, Ragsdale ST, Valentine MB, Behm FG, Li H, Heideman RL, Kun LE, Shapiro DN, Look AT.

Cancer Res. 1997 Sep 15;57(18):4042-7.

17.

Detection of genetic and chromosomal aberrations in medulloblastomas and primitive neuroectodermal tumors with DNA microarrays.

Kagawa N, Maruno M, Suzuki T, Hashiba T, Hashimoto N, Izumoto S, Yoshimine T.

Brain Tumor Pathol. 2006 Apr;23(1):41-7.

PMID:
18095118
18.

Genomic aberrations in carcinomas of the uterine corpus.

Micci F, Teixeira MR, Haugom L, Kristensen G, Abeler VM, Heim S.

Genes Chromosomes Cancer. 2004 Jul;40(3):229-46.

PMID:
15139002
19.

Detection of oncogene amplifications in medulloblastomas by comparative genomic hybridization and array-based comparative genomic hybridization.

Tong CY, Hui AB, Yin XL, Pang JC, Zhu XL, Poon WS, Ng HK.

J Neurosurg. 2004 Feb;100(2 Suppl Pediatrics):187-93.

PMID:
14758948
20.

Involvement of the long arm of chromosome 9 in medulloblastoma in an adult.

López-Ginés C, Cerdá-Nicolás M, Gil-Benso R, Barcia-Salorio JL, Llombart-Bosch A.

Cancer Genet Cytogenet. 1997 Jul 1;96(1):81-4.

PMID:
9209474

Supplemental Content

Support Center